Keywords: Diagnosis/Prediction, AI/ML Software, liver fibrosis, MRI, EHR
Motivation: Chronic liver diseases can lead to variable liver fibrosis. Percutaneous liver biopsy is the clinical standard; however, it has limitations.
Goal(s): Develop an ensemble learning model to stratify liver fibrosis using non-invasive clinical MRI and EHR data.
Approach: In this retrospective, multi-site study, we retrieved liver tissue specimens, multi-modal MRI, and EHR data. Using biopsy-derived liver fibrosis stages as reference, a stacking ensemble learning model was trained to classify a patient into the no/mild or advanced liver fibrosis.
Results: Using multi-modal MRI and EHR data, our model achieved an AUROCs of 0.69 – 0.75 on liver fibrosis stratification in internal and external cohorts.
Impact: Our study demonstrated that an ensemble learning model had a moderate performance in stratifying liver fibrosis using clinical multi-modal MRI and EHR data. With further tuning, it provides a potential non-invasive means for monitoring and screening of liver fibrosis.
How to access this content:
For one year after publication, abstracts and videos are only open to registrants of this annual meeting. Registrants should use their existing login information. Non-registrant access can be purchased via the ISMRM E-Library.
After one year, current ISMRM & ISMRT members get free access to both the abstracts and videos. Non-members and non-registrants must purchase access via the ISMRM E-Library.
After two years, the meeting proceedings (abstracts) are opened to the public and require no login information. Videos remain behind password for access by members, registrants and E-Library customers.
Keywords